par Tré-Hardy, Marie
;Traore, Hamidou
;El Manssouri, Naïma
;Vanderbist, Francis
;Vaneechoutte, Mario;Devleeschouwer, Michel 
Référence International journal of antimicrobial agents, 34, 4, page (370-374)
Publication Publié, 2009-10
;Traore, Hamidou
;El Manssouri, Naïma
;Vanderbist, Francis
;Vaneechoutte, Mario;Devleeschouwer, Michel 
Référence International journal of antimicrobial agents, 34, 4, page (370-374)
Publication Publié, 2009-10
Article révisé par les pairs
| Titre: |
|
| Auteur: | Tré-Hardy, Marie; Traore, Hamidou; El Manssouri, Naïma; Vanderbist, Francis; Vaneechoutte, Mario; Devleeschouwer, Michel |
| Informations sur la publication: | International journal of antimicrobial agents, 34, 4, page (370-374) |
| Statut de publication: | Publié, 2009-10 |
| Sujet CREF: | Sciences pharmaceutiques |
| Sciences bio-médicales et agricoles | |
| Mots-clés: | Cystic fibrosis |
| Mature biofilm | |
| Pseudomonas aeruginosa | |
| Synergistic activity | |
| Treatment simulation | |
| MeSH keywords: | Anti-Bacterial Agents -- administration & dosage -- pharmacology -- therapeutic use |
| Biofilms -- drug effects -- growth & development | |
| Clarithromycin -- administration & dosage -- pharmacology -- therapeutic use | |
| Colony Count, Microbial | |
| Cystic Fibrosis -- microbiology | |
| Drug Administration Schedule | |
| Drug Synergism | |
| Drug Therapy, Combination | |
| Genotype | |
| Humans | |
| Models, Biological | |
| Phenotype | |
| Pseudomonas aeruginosa -- drug effects -- genetics -- growth & development -- isolation & purification | |
| Sputum -- microbiology | |
| Time Factors | |
| Tobramycin -- administration & dosage -- pharmacology -- therapeutic use | |
| Treatment Outcome | |
| Note générale: | Evaluation Studies |
| Journal Article | |
| Research Support, Non-U.S. Gov't | |
| SCOPUS: ar.j | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:0924-8579 |
| info:doi/10.1016/j.ijantimicag.2009.04.010 | |
| info:pii/S0924-8579(09)00212-X | |
| info:scp/67651218977 | |
| info:pmid/19505804 |



